OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy

Neurology Today in 5

English - June 01, 2023 04:00 - 5 minutes - 7.24 MB - ★★★★★ - 14 ratings
Science Health & Fitness Medicine neurology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Assay detects Parkinson’s before symptom onset; life stressors in pregnant women with epilepsy; role of inflammation in NORSE

Next Episode: Antipsychotic for dementia-related agitation, contaminated water at Camp Lejeune associated with elevated risk for Parkinson’s, gene variant confers resilience against autosomal dominant Alzheimer’s.

In this week’s podcast, Neurology Today’s editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.